Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer

The aim of the study is to explore the efficacy and safety of dendritic cell-cytokine-induced killer cell (DC-CIK) immunotherapy combined with chemotherapy in the treatment of locally advanced gastric cancer (LAGC). Among 106 patients with LAGC, 53 received the treatment of oxaliplatin-5-fluorouraci...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guiyuan, Chen, Dehu, Zhao, Xiaojun, You, Xiaolan, Huang, Chuanjiang, Cheng, Zhiyi, Mao, Xunan, Zhou, Haihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296289/
https://www.ncbi.nlm.nih.gov/pubmed/35865086
http://dx.doi.org/10.1155/2022/5473292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296289/
https://www.ncbi.nlm.nih.gov/pubmed/35865086
http://dx.doi.org/10.1155/2022/5473292

Ejemplares similares